{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:21:35Z","timestamp":1777807295852,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007815","name":"District of Columbia Center for AIDS Research","doi-asserted-by":"publisher","award":["P30AU117970"],"award-info":[{"award-number":["P30AU117970"]}],"id":[{"id":"10.13039\/100007815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI125097"],"award-info":[{"award-number":["R01-AI125097"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21-AI157864"],"award-info":[{"award-number":["R21-AI157864"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jneuroim.2024.578294","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T11:30:58Z","timestamp":1705923058000},"page":"578294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report"],"prefix":"10.1016","volume":"388","author":[{"given":"Marta","family":"Sanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Chernet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Shymansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Chitrakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Soriano-Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2024.578294_bb0005","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2024.578294_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2024.578294_bb0015","series-title":"International Retrovirology Association Guidelines for the Management of HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis, 2018","author":"Araujo","year":"2018"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578294_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/CPJ.0000000000000832","article-title":"Management of HAM\/TSP: systematic review and consensus-based recommendations 2021","volume":"11","author":"Araujo","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2024.578294_bb0030","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.jneuroim.2024.578294_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/JLB.MA1118-467R","article-title":"Phenotypic and functional changes in gamma delta T lymphocytes from HTLV-1 carriers","volume":"106","author":"Cavalcanti De Albuquerque","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578294_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-019-0499-5","article-title":"Immunovirological markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"16","author":"Enose-Akahata","year":"2019","journal-title":"Retrovirology"},{"key":"10.1016\/j.jneuroim.2024.578294_bb0050","series-title":"Immunotherapy in Transplantation: Principles and Practice","first-page":"182","article-title":"Pharmacokinetic and pharmacodynamic properties of mycophenolate","author":"Hager","year":"2012"},{"issue":"2","key":"10.1016\/j.jneuroim.2024.578294_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-510X(00)00332-4","article-title":"HTLV-I-associated myelopathy manifested after renal transplantation","volume":"177","author":"Nakatsuji","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578294_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v14102084","article-title":"Hijacking host immunity by the human T-cell leukemia virus type-1: implications for therapeutic and preventative vaccines","volume":"14","author":"Pise-Masison","year":"2022","journal-title":"Viruses"},{"issue":"39","key":"10.1016\/j.jneuroim.2024.578294_bb0070","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene."},{"key":"10.1016\/j.jneuroim.2024.578294_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12879-019-4032-1","article-title":"Functional capacity of natural killer cells in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients","volume":"19","author":"Queiroz","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578294_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","article-title":"Mogamulizumab (anti-CCR4) in HTLV-1-associated myelopathy","volume":"378","author":"Sato","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2024.578294_bb0085","doi-asserted-by":"crossref","first-page":"1027158","DOI":"10.3389\/fimmu.2022.1027158","article-title":"Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578294_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13023-019-1212-4","article-title":"Real-world clinical course of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Japan","volume":"14","author":"Tsutsumi","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jneuroim.2024.578294_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus Type-1 associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jneuroim.2024.578294_bib101","doi-asserted-by":"crossref","first-page":"107669","DOI":"10.1016\/j.pharmthera.2020.107669","article-title":"An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers","volume":"218","author":"Yamauchi","year":"2021","journal-title":"Pharmacol. Ther."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:49:20Z","timestamp":1777495760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":17,"alternative-id":["S0165572824000122"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578294","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578294"}}